Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1965 1
1968 1
1970 1
1971 2
1972 6
1973 18
1974 15
1975 30
1976 35
1977 29
1978 16
1979 18
1980 20
1981 24
1982 14
1983 22
1984 15
1985 11
1986 15
1987 17
1988 13
1989 9
1990 19
1991 22
1992 5
1993 14
1994 6
1995 12
1996 6
1997 6
1998 13
1999 7
2000 18
2001 8
2002 14
2003 32
2004 40
2005 44
2006 51
2007 71
2008 52
2009 64
2010 92
2011 113
2012 145
2013 135
2014 144
2015 185
2016 225
2017 282
2018 397
2019 587
2020 870
2021 999
2022 664
Text availability
Article attribute
Article type
Publication date

Search Results

5,025 results
Results by year
Filters applied: . Clear all
Page 3
Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain.
Porter B, Marie BS, Milavetz G, Herr K. Porter B, et al. J Gerontol Nurs. 2021 Jul;47(7):6-15. doi: 10.3928/00989134-20210610-02. Epub 2021 Jul 1. J Gerontol Nurs. 2021. PMID: 34191653 Free PMC article. Review.
Legalization of cannabidiol (CBD) products has ignited interest in clinical practice and research. ...
Legalization of cannabidiol (CBD) products has ignited interest in clinical practice and research. ...
The Role of Cannabidiol in Neurological Disorders.
Chayasirisobhon S. Chayasirisobhon S. Perm J. 2021 May;25:20.156. doi: 10.7812/TPP/20.156. Perm J. 2021. PMID: 33970090 Free PMC article. Review.
Cannabidiol is a nonpsychotropic chemical and therefore has become a compound of interest for clinical researchers to study its therapeutic potential. This article reviews the efficacy and safety of cannabidiol in various neurological disorders in humans....
Cannabidiol is a nonpsychotropic chemical and therefore has become a compound of interest for clinical researchers to study its thera
Cannabidiol - A new fixture in childhood neurology.
Anderson CL, Carney PR. Anderson CL, et al. Curr Opin Pharmacol. 2021 Dec;61:142-146. doi: 10.1016/j.coph.2021.10.002. Epub 2021 Nov 19. Curr Opin Pharmacol. 2021. PMID: 34808574 Review.
This invited opinion article reviews current uses and controversies in vernacular and pharmacological cannabidiol use in pediatric neurologic disorders. Since the recent emergence of cannabidiol availability to the general public and recent Food and Drug Administrat …
This invited opinion article reviews current uses and controversies in vernacular and pharmacological cannabidiol use in pediatric ne …
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.
McGuire P, Robson P, Cubala WJ, Vasile D, Morrison PD, Barron R, Taylor A, Wright S. McGuire P, et al. Am J Psychiatry. 2018 Mar 1;175(3):225-231. doi: 10.1176/appi.ajp.2017.17030325. Epub 2017 Dec 15. Am J Psychiatry. 2018. PMID: 29241357 Clinical Trial.
OBJECTIVE: Research in both animals and humans indicates that cannabidiol (CBD) has antipsychotic properties. The authors assessed the safety and effectiveness of CBD in patients with schizophrenia. ...
OBJECTIVE: Research in both animals and humans indicates that cannabidiol (CBD) has antipsychotic properties. The authors assessed th …
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.
Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M. Boggs DL, et al. Neuropsychopharmacology. 2018 Jan;43(1):142-154. doi: 10.1038/npp.2017.209. Epub 2017 Sep 6. Neuropsychopharmacology. 2018. PMID: 28875990 Free PMC article. Review.
There are >550 chemical compounds and >100 phytocannabinoids isolated from cannabis, including delta(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is thought to produce the main psychoactive effects of cannabis, while CBD does not appear to have similar ef …
There are >550 chemical compounds and >100 phytocannabinoids isolated from cannabis, including delta(9)-tetrahydrocannabinol (THC) and …
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.
Bielawiec P, Harasim-Symbor E, Chabowski A. Bielawiec P, et al. Front Endocrinol (Lausanne). 2020 Mar 4;11:114. doi: 10.3389/fendo.2020.00114. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32194509 Free PMC article. Review.
Currently, much attention is paid to Cannabis derivatives-phytocannabinoids, which interact with the endocannabinoid system (ECS) constituents. delta(9)-tetrahydrocannabinol (delta(9)-THC) and cannabidiol (CBD) are the most abundant compounds of Cannabis plants and their t …
Currently, much attention is paid to Cannabis derivatives-phytocannabinoids, which interact with the endocannabinoid system (ECS) constituen …
Cannabidiol-induced toxicity: who is the culprit?
Vodovar D, Caré W, Dufayet L, Batisse A. Vodovar D, et al. Am J Emerg Med. 2021 Sep;47:284-285. doi: 10.1016/j.ajem.2021.06.002. Epub 2021 Jun 5. Am J Emerg Med. 2021. PMID: 34112527 No abstract available.
Emerging potential of cannabidiol in reversing proteinopathies.
Dash R, Ali MC, Jahan I, Munni YA, Mitra S, Hannan MA, Timalsina B, Oktaviani DF, Choi HJ, Moon IS. Dash R, et al. Ageing Res Rev. 2021 Jan;65:101209. doi: 10.1016/j.arr.2020.101209. Epub 2020 Nov 9. Ageing Res Rev. 2021. PMID: 33181336 Review.
Along with oxidative stress and neuroinflammation, disruption in protein homeostasis (proteostasis), a network that constitutes protein surveillance system, plays a pivotal role in the pathobiology of these dementia disorders. Cannabidiol (CBD), a non-psychotropic phytocan …
Along with oxidative stress and neuroinflammation, disruption in protein homeostasis (proteostasis), a network that constitutes protein surv …
Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies.
Schoevers J, Leweke JE, Leweke FM. Schoevers J, et al. Curr Opin Psychiatry. 2020 May;33(3):185-191. doi: 10.1097/YCO.0000000000000596. Curr Opin Psychiatry. 2020. PMID: 32073423 Review.
Regarding side effects and tolerability, cannabidiol induced sedation in one study, with the other studies indicating good tolerability, even at high doses. SUMMARY: Recent clinical trials added further evidence for an antipsychotic potential of cannabidiol. In gene …
Regarding side effects and tolerability, cannabidiol induced sedation in one study, with the other studies indicating good tolerabili …
5,025 results